FDA responds to Congressional inquiry regarding the Agency’s policies on Untitled Letters.
- As previously covered on this blog, the U.S. House Committee on Energy and Commerce requested information from
UNTITLED LETTER
Untitled
Posted on
Congress questions FDA policy regarding the publication of Untitled Letters.
- FDA has the authority to issue two types of letters to regulated entities: Warning Letters and Untitled Letters. FDA issues